• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Frequency of Her2/Neu Protein Expression in Ovarian Epithelial Cancers.

作者信息

Jafri Anum, Rizvi Sarwat

机构信息

Department of Pathology, King Edward Medical University, Lahore.

Associate Professor, Lady Willingdon Hospital, Lahore.

出版信息

J Coll Physicians Surg Pak. 2017 Sep;27(9):544-546.

PMID:29017668
Abstract

OBJECTIVE

To detect the frequency of Her-2/neu protein expression in epithelial ovarian cancers by immunohistochemistry.

STUDY DESIGN

Descriptive cross-sectional study.

PLACE AND DURATION OF STUDY

Department of Pathology, King Edward Medical University, Lahore, from July 2014 to May 2015.

METHODOLOGY

Fifty-six cases diagnosed as epithelial ovarian cancer on histopathology were included in this study. Immunohistochemistry was performed to observe the pattern of HER2/neu protein expression in these cases. Association with age was determined by Chi-square test with significance at p<0.05.

RESULTS

Out of these 56 cases, 38 (67.9%) were serous cystadenocarcinomas, 11 (19.6%) were endometrioid adenocarcinomas, 6 (10.7%) were mucinous cystadenocarcinomas and 1 (1.8%) was non-Brenner transitional cell carcinoma. The mean age of patients was 49.61 ±13.20 years with minimum and maximum ages of 21 years and 80 years, correspondingly. Twentyone (37.5%) out of 56 patients were found to overexpress Her-2/neu protein.

CONCLUSION

Her-2/neu protein overexpression was observed in 21 (37.5%) patients. No statistically significant association was seen between age and Her-2/neu protein overexpression.

摘要

相似文献

1
Frequency of Her2/Neu Protein Expression in Ovarian Epithelial Cancers.
J Coll Physicians Surg Pak. 2017 Sep;27(9):544-546.
2
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].[PAX8、PAX2、p53和RAS在卵巢及输卵管中的表达及其对卵巢高级别浆液性癌起源的意义]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008.
3
Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.Her-2/neu在早期卵巢表面上皮性肿瘤中的表达及扩增
Gynecol Oncol. 2004 Dec;95(3):570-5. doi: 10.1016/j.ygyno.2004.08.043.
4
Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.KIF2A和HER2-Neu过表达在上皮性卵巢癌患者中的预后价值
Medicine (Baltimore). 2016 Feb;95(8):e2803. doi: 10.1097/MD.0000000000002803.
5
Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.HER2/neu、雌激素和孕激素受体、CA 125及CA19-9在卵巢浆液性和黏液性癌患者癌细胞膜上的表达
J BUON. 2009 Oct-Dec;14(4):635-9.
6
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.在非浆液性上皮性卵巢癌患者中,FOXM1表达与化疗耐药及不良预后显著相关。
J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y.
7
Lack of prognostic significance of HER-2/neu in early epithelial ovarian cancer.HER-2/neu在早期上皮性卵巢癌中缺乏预后意义。
Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):502-6.
8
Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status in ovarian cancer.胰岛素样生长因子-1受体的阳性表达与卵巢癌中的激素受体阳性状态相关。
Eur J Gynaecol Oncol. 2016;37(2):204-10.
9
Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma.HER-2/neu的过表达不是卵巢透明细胞腺癌的危险因素。
Gynecol Oncol. 2004 Sep;94(3):735-9. doi: 10.1016/j.ygyno.2004.05.055.
10
Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer.
Cancer. 1994 Mar 1;73(5):1456-9. doi: 10.1002/1097-0142(19940301)73:5<1456::aid-cncr2820730522>3.0.co;2-l.

引用本文的文献

1
Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy.针对源自患者的异种移植卵巢癌模型中的 HER2 可使肿瘤对化疗敏感。
Mol Oncol. 2019 Feb;13(2):132-152. doi: 10.1002/1878-0261.12414. Epub 2018 Dec 21.